A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volunteers

NCT02236026 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Supratherapuetic dose of Nestorone
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Population Council

Collaborators

[object Object]